Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome

Joseph Rubin, Jaffer Ajani, William Schirmer, Alan P. Venook, Ronald Bukowski, Rodney Pommier, Leonard Saltz, Paresh Dandona, Lowell Anthony

Research output: Contribution to journalArticlepeer-review

357 Scopus citations

Fingerprint

Dive into the research topics of 'Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science